| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6829276 | Schizophrenia Research | 2007 | 8 Pages |
Abstract
The results indicate that frequent cannabis exposure may down-regulate anandamide signaling in the CNS of schizophrenic patients, but not of healthy individuals. Thus, our findings suggest that alterations in endocannabinoid signaling might be an important component of the mechanism through which cannabis impacts mental health.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
F. Markus Leweke, Andrea Giuffrida, Dagmar Koethe, Daniela Schreiber, Brit M. Nolden, Laura Kranaster, Miriam A. Neatby, Miriam Schneider, Christoph W. Gerth, Martin Hellmich, Joachim Klosterkötter, Daniele Piomelli,